Pierre Colombe Dromel: Restoring Vision with Cell Therapy and Tissue Engineering
Pierre: Thanks for having me, Spiffy! At InGel, we are creating novel cell therapies and tissue engineering solutions to treat patients affected by blinding disease, also known as retinal degenerative diseases. Most of these patients have no treatment and dread the day when the last ray of light will enter their eyes and they will wake up permanently blind. Our mission is to bring back light to these patients using our innovation. Our technology is gene agnostic, has shown tremendous pre-clinical efficacy and safety, and can be used to treat many different indications, such as Retinitis Pigmentosa and Dry-AMD.
